Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
European Journal of Medicinal Chemistry|August 29, 2012
Anticancer siRNA delivery by new anticancer molecule: a novel combination strategy for cancer cell killingPrathap Reddy Muktapuram, Rishi Kumar Gara, Komal Sharma, et al.
Developmental Biology|July 11, 2008
Nuclear regulator Pygo2 controls spermiogenesis and histone H3 acetylationMahalakshmi Nair, Ippei Nagamori, Peng Sun, et al.
Journal of Biomedical Science|April 17, 2015
Shikonin selectively induces apoptosis in human prostate cancer cells through the endoplasmic reticulum stress and mitochondrial apoptotic pathwayRishi Kumar Gara, Vikas Kumar Srivastava, Shivali Duggal, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 26, 2016
Evaluation of KiSS1 as a Prognostic Biomarker in North Indian Breast Cancer CasesRicha Singh, Madan Lal Brahma Bhatt, Saurabh Pratap Singh, et al.
Toxicology Research|April 15, 2024
Short term biodistribution and in vivo toxicity assessment of intravenously injected pristine graphene oxide nanoflakes in SD ratsIndranil De, Rashmika Singh, Sushil Kumar, et al.
Journal of Chemical Information and Modeling|December 28, 2019
Computational Design of Biologically Active Anticancer Peptides and Their Interactions with Heterogeneous POPC/POPS Lipid MembranesManinder Singh, Vikash Kumar, Kamakshi Sikka, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 19, 2025
Targeting RUNX3/PARP1 signaling ameliorates colorectal cancer cachexiaAbinash Swain, Pinaki Prasad Mahapatra, Abhishek Nirwan, et al.
Future Medicinal Chemistry|June 27, 2025
Repurposing sulfonamide-scaffolds for enhanced and sustainable malaria therapyDurga Prasad Mishra, Roja Sahu, Prafulla Kumar Sahu, et al.
Biomaterials Advances|December 4, 2025
Demystifying targeting potential of surface-functionalized liposome for BTK inhibitor delivery in breast cancer therapy: Multiphase validation from in-silico to in-vivoIndrani Maji, Ezhilmathe Athavan, Sharon Munagalasetty, et al.
Oncotarget|December 2, 2015
Proteasome inhibition mediates p53 reactivation and anti-cancer activity of 6-gingerol in cervical cancer cellsNamrata Rastogi, Shivali Duggal, Shailendra Kumar Singh, et al.
Pageof 7